AI Prescribing Medications: Promise Meets Patient Safety Concerns
Utah has authorized AI to renew prescriptions while 40 million Americans turn to ChatGPT daily for health advice. These parallel developments mark a watershed moment in healthcare delivery—one that promises improved access but raises urgent questions about patient safety, liability, and the appropriate boundaries for autonomous medical decision-making.
FDA’s Regulatory Pullback on AI and Wearables
The FDA has announced sweeping changes to its oversight of AI-enabled devices and consumer wearables, exempting non-medical-grade wearable data from regulation. As federal oversight recedes, health systems face growing responsibility for validating technologies, managing liability risks, and establishing governance frameworks. This regulatory shift creates both opportunities for innovation and challenges for organizations navigating an uncertain liability landscape with limited precedents.
Clinical AI’s Hidden Risks: What New Research Reveals
New research from MIT, Stanford, and Vanderbilt reveals critical vulnerabilities in clinical AI systems—from miscalculated risk assessments to data memorization issues—that could compromise patient safety. As AI increasingly guides healthcare decisions, these findings underscore the urgent need for rigorous validation, transparent limitations, and sustained physician oversight to balance innovation with responsible implementation.